Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial

I. Winter, M. Davidson, W. Fleischhacker, R. Kahn

Open source

DOI
10.1192/j.eurpsy.2022.356
Published
June
Container
European Psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1192/j.eurpsy.2022.356,
  title = {Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial},
  author = {I. Winter and M. Davidson and W. Fleischhacker and R. Kahn},
  year = {2022},
  journal = {European Psychiatry},
  doi = {10.1192/j.eurpsy.2022.356},
  url = {https://doi.org/10.1192/j.eurpsy.2022.356}
}

RIS

TY  - JOUR
TI  - Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial
AU  - I. Winter
AU  - M. Davidson
AU  - W. Fleischhacker
AU  - R. Kahn
PY  - 2022
JO  - European Psychiatry
DO  - 10.1192/j.eurpsy.2022.356
UR  - https://doi.org/10.1192/j.eurpsy.2022.356
ER  - 

APA

Winter, I., Davidson, M., Fleischhacker, W., & Kahn, R. (2022). Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.356

Source records